Experts say strong evidence of efficacy needed to avoid approval of inferior vaccines
* Coronavirus – latest updates
* See all our coronavirus coverage
The rush to immunise populations against Covid-19 could lead to the rollout of a vaccine that is not very effective and risk worsening the pandemic, leading scientists have said.
Politicians and commercial companies are competing to be the first to license a vaccine, but experts say the world would be better served by waiting until comprehensive results showed at least 30-50% effectiveness. Continue reading...
http://dlvr.it/RffDK5
Post a Comment